查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
急速自我修復凝膠的全球市場:市場規模 - 各架橋類型，各用途，各地區展望，競爭策略，各市場區隔預測(～2032年)
市場調查報告書
商品編碼
1213648

急速自我修復凝膠的全球市場:市場規模 - 各架橋類型，各用途，各地區展望，競爭策略，各市場區隔預測(～2032年)

Rapid Self-Healing Gel Market Size- By Crosslinking Type, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2032
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 241 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球急速自我修復凝膠的市場規模，預計至2032年達到5億1,000萬美元，以8.61％的年複合成長率成長。

由於外傷和慢性創傷增加，在預測期間內預計市場成長。再加上為了提高急速自我修復凝膠的有效性的臨床試驗更大量實施，預計市場擴大。

本報告提供全球急速自我修復凝膠市場相關調查，市場動態，市場變數與展望，競爭情形，各架橋類型、用途、地區的市場分析，企業簡介等相關資訊。

目錄

第1章 簡介

  • 調查範圍
  • 市場區隔分析

第2章 調查手法

  • 調查資料來源
  • 市場規模的估計
  • 資料的三角測量

第3章 摘要整理

第4章 市場動態

  • 促進因素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 全球急速自我修復凝膠市場上COVID-19的影響

第5章 市場變數與展望

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術形勢
    • 環境形勢
    • 法律上的形勢
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 競爭情形

  • 全球急速自我修復凝膠的製造地流通，銷售區域，產品類型
  • 全球急速自我修復凝膠市場的合併、收購，夥伴關係，產品銷售，合作

第7章 全球急速自我修復凝膠市場:各架橋類型(2019年～2032年(100萬美元))

  • 化學
  • 物理

第8章 全球急速自我修復凝膠市場:各用途(2019年～2032年(100萬美元))

  • 3D印刷
  • 藥物運輸
  • 表面塗料
  • 組織工程
  • 創傷治療
  • 其他

第9章 全球急速自我修復凝膠市場:各地區(2019年～2032年(100萬美元))

  • 全球急速自我修復凝膠的規模、市場佔有率:各地區(2019年～2025年)
  • 全球急速自我修復凝膠的規模、市場佔有率:各地區(2026年～2032年)
  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他的歐洲
  • 中東、非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他的中東、非洲
  • 北美
    • 加拿大
    • 墨西哥
    • 美國
  • 南美
    • 阿根廷
    • 巴西
    • 其他的南美

第10章 企業簡介

  • Advanced Medical Solutions Group PLC
    • 企業概要
    • 財務展望
    • 產品概要
    • 最近的開發
  • Alliqua Biomedical
  • Axelgaard
  • Cardinal Health
  • Contura International
  • Cytogel Pharma
  • Hydromer Inc.
  • Katecho Inc.
  • R&D Medical Products Inc.
  • Scapa Healthcare

第11章 簡稱一覽

第12章 參照鏈接

第13章 結論

第14章 調查範圍

簡介目錄
Product Code: PHAR2302

Global Rapid Self-Healing Gel Market Overview

According to SPER Market Research, the Global Rapid Self-Healing Gel Market is estimated to reach USD 0.51 billion by 2032 with a CAGR of 8.61%.

A unique variety of polymer hydrogel known as rapid self-healing gel is a cross-network of polymers connected to one another by chemical or physical interactions such as hydrogen bonds, ionic interactions, and others between the unit polymers. These gels have a very high capacity for hydration, which makes them elastic, sensitive, and permeable. The three-dimensional structure of these gels can also be maintained in spite of environmental changes including mechanical and physical degradation. Researchers can use quick self-healing gels in a range of biomedical applications, such as tissue engineering, wound healing, medication delivery, cosmetology, and others, thanks to the hydrogel's ability to simulate flesh or skin. The market for quick self-healing gel is expected to grow over the course of the projection period as a result of the rise in trauma and chronic wound situations. Additionally, it is projected that the market would expand over the course of the projection period as more clinical trials are carried out to improve the effectiveness of rapid self-healing gel. Expanding R&D activities may facilitate the development of novel rapid self-healing gels, which is projected to drive the growth of the global market for these gels during the ensuing years.

Rapid Self-Healing Gel Market

Impact of COVID-19 on the Global Rapid Self-Healing Gel Market

The COVID-19 epidemic caused a drop in the market for Rapid Self-healing Gel. The world has been negatively impacted by this deadly virus, particularly North America and Europe. Companies have shut down their operations and manufacturing facilities, and the government has curtailed production activities to stop the virus from spreading further. All industries have seen a decrease in the use of Rapid Self-healing Gel as a result. However, there aren't any limits at the moment, and the virus's spread is likewise under control. The availability of raw materials needed for the production of self-healing gel during the pandemic was constrained due to the effects of the coronavirus (COVID-19) epidemic. As a result, it is anticipated that the COVID-19 pandemic will impede the market for rapid self-healing gel. Consequently, businesses are growing and fostering healthy competition for the Rapid Self-healing Gel market.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Crosslinking Type, By Application
  • Regions covered: Asia Pacific, Europe, Middle East and Africa, North America, Latin America
  • Companies Covered: Advanced Medical Solutions Group PLC, Alliqua Biomedical, Axelgaard, Cardinal Health, Contura International, Cytogel Pharma, Hydromer Inc., Katecho Inc., R&D Medical Products Inc., Scapa Healthcare

Global Rapid Self-Healing Gel Market Segmentation:

  • By Crosslinking Type: Based on the Crosslinking Type, Global Rapid Self-Healing Gel Market is segmented as; Chemical, Physical.
  • By Application: Based on the Application, Global Rapid Self-Healing Gel Market is segmented as; 3D Printing, Drug Delivery, Surface Coating, Tissue Engineering, Wound Healing, Others.
  • By Region: The market for rapid self-healing gel is anticipated to be dominated by North America over the course of the forecast period due to the increased prevalence of chronic wounds. For instance, according to Ecronicon, millions of Americans experience pressure ulcers every year. This is anticipated to fuel the market for self-healing gel to grow quickly in North America.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Rapid Self-Healing Gel Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Competitive Landscape

  • 6.1 Global Rapid Self-Healing Gel Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Rapid Self-Healing Gel Market

7. Global Rapid Self-Healing Gel Market, By Crosslinking Type, 2019-2032 (USD Million)

  • 7.1 Chemical
  • 7.2 Physical

8. Global Rapid Self-Healing Gel Market, By Application, 2019-2032 (USD Million)

  • 8.1 3D Printing
  • 8.2 Drug Delivery
  • 8.3 Surface Coating
  • 8.4 Tissue Engineering
  • 8.5 Wound Healing
  • 8.6 Others

9. Global Rapid Self-Healing Gel Market, By Region, 2019-2032 (USD Million)

  • 9.1 Global Rapid Self-Healing Gel Size and Market Share by Region (2019-2025)
  • 9.2 Global Rapid Self-Healing Gel Size and Market Share by Region (2026-2032)
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Europe
    • 9.4.1 France
    • 9.4.2 Germany
    • 9.4.3 Italy
    • 9.4.4 Spain
    • 9.4.5 United Kingdom
    • 9.4.6 Rest of Europe
  • 9.5 Middle East & Africa
    • 9.5.1 Kingdom of Saudi Arabia
    • 9.5.2 United Arab Emirates
    • 9.5.3 Rest of Middle East & Africa
  • 9.6 North America
    • 9.6.1 Canada
    • 9.6.2 Mexico
    • 9.6.3 United States
  • 9.7 Latin America
    • 9.7.1 Argentina
    • 9.7.2 Brazil
    • 9.7.3 Rest of Latin America

10. Company Profiles

  • 10.1 Advanced Medical Solutions Group PLC
    • 10.1.1 Company details
    • 10.1.2 Financial outlook
    • 10.1.3 Product summary
    • 10.1.4 Recent developments
  • 10.2 Alliqua Biomedical
    • 10.2.1 Company details
    • 10.2.2 Financial outlook
    • 10.2.3 Product summary
    • 10.2.4 Recent developments
  • 10.3 Axelgaard
    • 10.3.1 Company details
    • 10.3.2 Financial outlook
    • 10.3.3 Product summary
    • 10.3.4 Recent developments
  • 10.4 Cardinal Health
    • 10.4.1 Company details
    • 10.4.2 Financial outlook
    • 10.4.3 Product summary
    • 10.4.4 Recent developments
  • 10.5 Contura International
    • 10.5.1 Company details
    • 10.5.2 Financial outlook
    • 10.5.3 Product summary
    • 10.5.4 Recent developments
  • 10.6 Cytogel Pharma
    • 10.6.1 Company details
    • 10.6.2 Financial outlook
    • 10.6.3 Product summary
    • 10.6.4 Recent developments
  • 10.7 Hydromer Inc.
    • 10.7.1 Company details
    • 10.7.2 Financial outlook
    • 10.7.3 Product summary
    • 10.7.4 Recent developments
  • 10.8 Katecho Inc.
    • 10.8.1 Company details
    • 10.8.2 Financial outlook
    • 10.8.3 Product summary
    • 10.8.4 Recent developments
  • 10.9 R&D Medical Products Inc.
    • 10.9.1 Company details
    • 10.9.2 Financial outlook
    • 10.9.3 Product summary
    • 10.9.4 Recent developments
  • 10.10 Scapa Healthcare
    • 10.10.1 Company details
    • 10.10.2 Financial outlook
    • 10.10.3 Product summary
    • 10.10.4 Recent developments

11. List of Abbreviations

12. Reference Links

13. Conclusion

14. Research Scope